PharmaBoardroom

Italy: Menarini CEO on Averting Future Health Crises; Alfasigma…

A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with Menarini CEO Elcin Barker Ergun, a…

Thomas D. Szucs, European Center of Pharmaceutical Medicine at…

Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers and authorities are adapting to the…

Medigen’s Charles Chen on Cell Culture Vaccine Strategies

Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what…

US Pharma Innovation Factsheet 2020

In a recent article for PharmaBoardroom, Objective Capital's David Crean took a look at the state of US innovation today and its long term…

The Value Proposition of Generics & Biosimilars in the USA

AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value proposition of generic and…

Jürg Utzinger – Director, Swiss Tropical & Public…

Prof Dr Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) outlines the organisation’s important role within the global…

Why Europe Needs a Sustainable Pharma Manufacturing System

On 25 November, the European Commission adopted a new strategy meant to, among others, allow Europe to cover its pharmaceutical needs, including in…

Chinese Pharma Share Price Hit; Pfizer-LianBio Linkup; Novo’s…

The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of successful COVID-19 trial results from…

Ana Hidalgo-Simon – Head of Advanced Therapies, European…

The EMA’s Head of Advanced Therapies Dr Ana Hidalgo-Simon outlines Europe’s evolving regulatory framework for regenerative medicines, how it…

Asia-Pacific: World’s Largest Trade Deal’s Pharma Impact Too…

On 15 November 2020, the world’s largest trade deal in terms of GDP – the Regional Comprehensive Economic Partnership (RCEP) –was signed…

Cross Country Collaborations in Europe: The Future of Pricing…

Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland examines the trend of collaboration between European countries…

Novartis Oncology US: Leaning into Change

With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology has undergone a significant business…

Tagged with P